Works matching IS 09546820 AND DT 2021 AND VI 289 AND IP 3

Results: 19

Direct oral anticoagulant use and risk of severe COVID‐19.
Published in:
Journal of Internal Medicine, 2021, v. 289, n. 3, p. 411, doi. 10.1111/joim.13205
By:
- Flam, B.;
- Wintzell, V.;
- Ludvigsson, J. F.;
- Mårtensson, J.;
- Pasternak, B.
Publication type:
Article
Telehealth mitigates COPD disease progression compared to standard of care: a randomized controlled crossover trial.
Published in:
Journal of Internal Medicine, 2021, v. 289, n. 3, p. 404, doi. 10.1111/joim.13230
By:
- Rassouli, F.;
- Germann, A.;
- Baty, F.;
- Kohler, M.;
- Stolz, D.;
- Thurnheer, R.;
- Brack, T.;
- Kähler, C.;
- Widmer, S.;
- Tschirren, U.;
- Sievi, N. A.;
- Tamm, M.;
- Brutsche, M. H.
Publication type:
Article
The pathogenesis of microthrombi in COVID‐19 cannot be controlled by DOAC: NETosis should be the target.
Published in:
Journal of Internal Medicine, 2021, v. 289, n. 3, p. 420, doi. 10.1111/joim.13228
By:
- Gremese, E.;
- Ferraccioli, G.
Publication type:
Article
Response to Letter: 'Reply to "High frequency of antiphospholipid antibodies in critically ill COVID‐19 patients: a link with hypercoagulability?"'.
Published in:
Journal of Internal Medicine, 2021, v. 289, n. 3, p. 427, doi. 10.1111/joim.13166
By:
- Pineton de Chambrun, M.;
- Frere, C.;
- Miyara, M.;
- Amoura, Z.;
- Martin‐Toutain, I.;
- Mathian, A.;
- Hekimian, G.;
- Combes, A.
Publication type:
Article
A contemporary review of Clostridioides difficile infections in patients with haematologic diseases.
Published in:
Journal of Internal Medicine, 2021, v. 289, n. 3, p. 293, doi. 10.1111/joim.13173
By:
- Dutta, D.;
- Jafri, F.;
- Stuhr, D.;
- Knoll, B. M.;
- Lim, S. H.
Publication type:
Article
Clinical characteristics and outcomes of immunosuppressed patients hospitalized with COVID‐19: experience from London.
Published in:
Journal of Internal Medicine, 2021, v. 289, n. 3, p. 385, doi. 10.1111/joim.13172
By:
- Vaid, N.;
- Ardissino, M.;
- Reed, T. A. N.;
- Goodall, J.;
- Utting, P.;
- Miscampbell, M.;
- Condurache, D.;
- Cohen, D. L.
Publication type:
Article
Systemic amyloidosis from A (AA) to T (ATTR): a review.
Published in:
Journal of Internal Medicine, 2021, v. 289, n. 3, p. 268, doi. 10.1111/joim.13169
By:
- Muchtar, E.;
- Dispenzieri, A.;
- Magen, H.;
- Grogan, M.;
- Mauermann, M.;
- McPhail, E. D.;
- Kurtin, P. J.;
- Leung, N.;
- Buadi, F. K.;
- Dingli, D.;
- Kumar, S. K.;
- Gertz, M. A.
Publication type:
Article
Prognostic significance of present atrial fibrillation on a single office electrocardiogram in patients with atrial fibrillation.
Published in:
Journal of Internal Medicine, 2021, v. 289, n. 3, p. 395, doi. 10.1111/joim.13168
By:
- Krisai, P.;
- Hämmerle, P.;
- Blum, S.;
- Meyre, P.;
- Aeschbacher, S.;
- Melchiorre‐Mayer, P.;
- Baretella, O.;
- Rodondi, N.;
- Conen, D.;
- Osswald, S.;
- Kühne, M.;
- Zuern, C. S.
Publication type:
Article
Coronary artery calcium scoring: an evidence‐based guide for primary care physicians.
Published in:
Journal of Internal Medicine, 2021, v. 289, n. 3, p. 309, doi. 10.1111/joim.13176
By:
- Cheong, B. Y. C.;
- Wilson, J. M.;
- Spann, S. J.;
- Pettigrew, R. I.;
- Preventza, O. A.;
- Muthupillai, R.
Publication type:
Article
Eligibility for sacubitril/valsartan in heart failure across the ejection fraction spectrum: real‐world data from the Swedish Heart Failure Registry.
Published in:
Journal of Internal Medicine, 2021, v. 289, n. 3, p. 369, doi. 10.1111/joim.13165
By:
- Savarese, G.;
- Hage, C.;
- Benson, L.;
- Schrage, B.;
- Thorvaldsen, T.;
- Lundberg, A.;
- Fudim, M.;
- Linde, C.;
- Dahlström, U.;
- Rosano, G. M. C.;
- Lund, L. H.
Publication type:
Article
Use of the IL‐6R antagonist tocilizumab in hospitalized COVID‐19 patients.
Published in:
Journal of Internal Medicine, 2021, v. 289, n. 3, p. 430, doi. 10.1111/joim.13163
By:
- Patel, K.;
- Gooley, T. A.;
- Bailey, N.;
- Bailey, M.;
- Hegerova, L.;
- Batchelder, A.;
- Holdread, H.;
- Dunleavy, V.;
- Downey, T.;
- Frisvold, J.;
- Megrath, S.;
- Pagarigan, K.;
- Szeto, J.;
- Rueda, J.;
- Islam, A.;
- Maree, C.;
- Nyatsatsang, S.;
- Bork, S. E.;
- Lipke, A.;
- O'Mahony, D. S.
Publication type:
Article
Tocilizumab shortens time on mechanical ventilation and length of hospital stay in patients with severe COVID‐19: a retrospective cohort study.
Published in:
Journal of Internal Medicine, 2021, v. 289, n. 3, p. 434, doi. 10.1111/joim.13162
By:
- Eimer, J.;
- Vesterbacka, J.;
- Svensson, A.‐K.;
- Stojanovic, B.;
- Wagrell, C.;
- Sönnerborg, A.;
- Nowak, P.
Publication type:
Article
Vascular risk factor control and adherence to secondary preventive medication after ischaemic stroke.
Published in:
Journal of Internal Medicine, 2021, v. 289, n. 3, p. 355, doi. 10.1111/joim.13161
By:
- Gynnild, M. N.;
- Aakerøy, R.;
- Spigset, O.;
- Askim, T.;
- Beyer, M. K.;
- Ihle‐Hansen, H.;
- Munthe‐Kaas, R.;
- Knapskog, A. B.;
- Lydersen, S.;
- Næss, H.;
- Røsstad, T.G.;
- Seljeseth, Y. M.;
- Thingstad, P.;
- Saltvedt, I.;
- Ellekjær, H.
Publication type:
Article
Reply to "High frequency of Antiphospholipid Antibodies in Critically ill COVID‐19 patients: a Link with Hypercoagulability?".
Published in:
Journal of Internal Medicine, 2021, v. 289, n. 3, p. 425, doi. 10.1111/joim.13159
By:
- Suárez‐Pérez, L.;
- Coto‐Hernández, R.;
- Suárez‐Cuervo, C.;
- Caminal‐Montero, L.
Publication type:
Article
A systems biology approach to understand gut microbiota and host metabolism in morbid obesity: design of the BARIA Longitudinal Cohort Study.
Published in:
Journal of Internal Medicine, 2021, v. 289, n. 3, p. 340, doi. 10.1111/joim.13157
By:
- Van Olden, C. C.;
- Van de Laar, A. W.;
- Meijnikman, A. S.;
- Aydin, O.;
- Van Olst, N.;
- Hoozemans, J. B.;
- De Brauw, L. M.;
- Bruin, S. C.;
- Acherman, Y. I. Z.;
- Verheij, J.;
- Pyykkö, J. E.;
- Hagedoorn, M.;
- Sanderman, R.;
- Bosma, N. C.;
- Tremaroli, V.;
- Lundqvist, A.;
- Olofsson, L. E.;
- Herrema, H.;
- Lappa, D.;
- Hjorth, S.
Publication type:
Article
High frequency of antiphospholipid antibodies in critically ill COVID‐19 patients: a link with hypercoagulability?
Published in:
Journal of Internal Medicine, 2021, v. 289, n. 3, p. 422, doi. 10.1111/joim.13126
By:
- Pineton de Chambrun, M.;
- Frere, C.;
- Miyara, M.;
- Amoura, Z.;
- Martin‐Toutain, I.;
- Mathian, A.;
- Hekimian, G.;
- Combes, A.
Publication type:
Article
Patients with Lemierre syndrome have a high risk of new thromboembolic complications, clinical sequelae and death: an analysis of 712 cases.
Published in:
Journal of Internal Medicine, 2021, v. 289, n. 3, p. 325, doi. 10.1111/joim.13114
By:
- Valerio, L.;
- Zane, F.;
- Sacco, C.;
- Granziera, S.;
- Nicoletti, T.;
- Russo, M.;
- Corsi, G.;
- Holm, K.;
- Hotz, M.‐A.;
- Righini, C.;
- Karkos, P. D.;
- Mahmoudpour, S. H.;
- Kucher, N.;
- Verhamme, P.;
- Di Nisio, M.;
- Centor, R. M.;
- Konstantinides, S. V.;
- Pecci, A.;
- Barco, S.
Publication type:
Article
Issue Information.
Published in:
Journal of Internal Medicine, 2021, v. 289, n. 3, p. 267, doi. 10.1111/joim.13104
Publication type:
Article
Lemierre syndrome - treat with antibiotics, anticoagulants or both?
Published in:
2021
By:
- Schulman, S.
Publication type:
Editorial